A University of Dundee building in Dundee, Scotland

Credit: PhaSER Biomedical

Scottish biotech PhaSER Biomedical has won a $2.7M (£2m) grant from the Gates Foundation to help find new drugs for diseases such as TB and malaria. The company announced the award in a statement this morning.

The two-year grant renews PhaSER’s place in the foundation’s Global Health Discovery Collaboratory , a programme that gives Gates-funded teams access to shared lab tools. Through it, scientists around the world can use PhaSER’s mice and its know-how on how the body handles drugs.

The award follows a $2.3M Gates grant announced in 2024. During that period, researchers used PhaSER’s 8HUM model in work on tuberculosis, malaria, schistosomiasis and Chagas disease, the company said.

The 8HUM mouse carries human versions of the main genes that break down drugs. Mice usually clear drugs much faster than people do.…